TLOFX
Price
$9.18
Change
+$0.12 (+1.32%)
Updated
May 2 closing price
Net Assets
235.01M
VIVIX
Price
$65.79
Change
+$1.00 (+1.54%)
Updated
May 2 closing price
Net Assets
190.51B
Ad is loading...

TLOFX vs VIVIX

Header iconTLOFX vs VIVIX Comparison
Open Charts TLOFX vs VIVIXBanner chart's image
Transamerica Large Value Opps R4
Price$9.18
Change+$0.12 (+1.32%)
VolumeN/A
Net Assets235.01M
Vanguard Value Index I
Price$65.79
Change+$1.00 (+1.54%)
VolumeN/A
Net Assets190.51B
TLOFX vs VIVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
TLOFX vs. VIVIX commentary
May 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TLOFX is a Buy and VIVIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 191B vs. TLOFX (235M). VIVIX pays higher dividends than TLOFX: VIVIX (2.35) vs TLOFX (1.41). TLOFX was incepted earlier than VIVIX: TLOFX (25 years) vs VIVIX (27 years). TLOFX (0.75) is less costly to investors than VIVIX (0.04). TLOFX is a more actively managed with annual turnover of: 111.00 vs. VIVIX (9.00). TLOFX has a lower initial minimum investment than VIVIX: TLOFX (5000) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 7.67 vs. TLOFX (-9.45). VIVIX return over 5 years is better than : 76.44 vs. TLOFX (25.71).
TLOFXVIVIXTLOFX / VIVIX
Total Expense Ratio0.750.041,875%
Annual Report Gross Expense Ratio0.750.041,875%
Fund Existence25 years27 years-
Gain YTD-0.642-0.336191%
Front LoadN/AN/A-
Min. Initial Investment500050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets235M191B0%
Annual Yield % from dividends1.412.3560%
Returns for 1 year-9.457.67-123%
Returns for 3 years-3.3019.05-17%
Returns for 5 years25.7176.4434%
Returns for 10 years7.1998.847%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AEON0.500.06
+14.71%
AEON Biopharma
CASS41.600.30
+0.73%
Cass Information Systems
AVTE93.80N/A
N/A
Aerovate Therapeutics
INSM72.30-0.34
-0.47%
Insmed
CGEN1.48-0.04
-2.63%
Compugen Ltd